Clicky

NUMINUS WELLNESS INC.(LR23)

Description: Numinus Wellness Inc. provides psychedelic-assisted psychotherapy products and services in Canada and the United States. The company operates through Clinical Research Operations, Canadian Clinic Network, and U.S Clinic Network segments. The Clinical Research Operations segment offers clinical research management services to academic institutions and biotechnology companies. The Canadian Clinic Network segment provides clinical services, including traditional therapy and counseling, ketamine-assisted therapies for depression, psychedelic-assisted therapies, mindfulness programs, and virtual psychotherapy services, as well as neurological care services. The US clinic network segment offers psychedelic-assisted therapies, transcranial magnetic stimulation, and psychiatric and medical model management services. The company also offers laboratory services, such as the cultivation, production, and extraction of natural Psilocybe and other psychoactive fungi species, the development of proprietary processes and products, methods for controlled psychedelics and development of a pipeline for product development, and protocol development and safety and efficacy studies; lab testing services; and psychedelic-assisted therapy training services. The company was incorporated in 1964 and is headquartered in Vancouver, Canada.


Keywords: Biotechnology Laboratory Services Clinical Services Psychedelic Drug Psychotherapy Lab Testing Services Clinical Research Management Services Neurological Care Services Psychedelic Assisted Psychotherapy Products Psychedelic Assisted Therapy Training Services Psychedelic Therapy Psychiatric And Medical Model Management Services Therapies For Depression Virtual Psychotherapy Services

Home Page: www.numinus.com

666 Burrard Street
Vancouver, BC V6C 2X8
Canada
Phone: 833 686 4687


Officers

Name Title
Mr. Payton Nyquvest Founder, CEO & Chairman
Mr. Michael Tan M.B.A. President, COO & Director
Dr. Paul Thielking M.D. Chief Science & Medical Officer
Dr. Reid J. Robison M.D., MBA Chief Clinical Officer
Ms. Melony Valleau CPA Interim Chief Financial Officer
Jamie Kokoska Vice President of Investor Relations
Ms. Paula Amy Hewitt Senior VP, General Counsel & Chief Privacy Officer
Mr. Ian Noble Chief Communications Officer
Ms. Danielle Hinan Vice President Marketing
Ms. Lea Bottoni Vice President of People & Culture

Exchange: F

Country: DE : Germany

Currency: Euro (€)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 2.7326
Price-to-Sales TTM: 0.4337
IPO Date:
Fiscal Year End: August
Full Time Employees: 0
Back to stocks